27.6.2023
References
Avail advised Nordic Bioproducts Group on the EUR 30 million funding round by Taaleri’s bioindustry fund, Chilean CMPC and other investors
Avail advised Sentica-backed Hammas Hohde on the acquisition of Hammas & Hammas Pääkaupunkiseutu Oy. The acquisition supplements to Hammas Hohde’s dental clinics in Helsinki and Vantaa and strengthens its station network in the capital region. The four dental clinics of Hammas & Hammas in Kivenlahti, Espoo, and Hietalahti, Kamppi and Töölö in Helsinki will continue as independent clinics under the Hammas & Hammas brand.
